Clinical trial
Improved Monitoring and Prediction of Clinical Response and Disease Course During Golimumab Therapy of Patients With Axial Spondyloarthritis
NCT02011386 is registered in ClinicalTrials.gov with Professor Mikkel Østergaard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improved Monitoring and Prediction of Clinical Response and Disease Course During Golimumab Therapy of Patients With Axial Spondyloarthritis
- Lead sponsor
- Professor Mikkel Østergaard
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- February 14, 2017
- Enrollment
- 53 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.